Your browser doesn't support javascript.
loading
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.
Gilardi, Mara; Wang, Zhiyong; Proietto, Marco; Chillà, Anastasia; Calleja-Valera, Juan Luis; Goto, Yusuke; Vanoni, Marco; Janes, Matthew R; Mikulski, Zbigniew; Gualberto, Antonio; Molinolo, Alfredo A; Ferrara, Napoleone; Gutkind, J Silvio; Burrows, Francis.
Afiliação
  • Gilardi M; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Wang Z; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Proietto M; Section of Molecular Biology, Division of Biological Sciences, University of California San Diego, La Jolla, California.
  • Chillà A; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Calleja-Valera JL; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota.
  • Goto Y; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Vanoni M; Department of Biotechnology and Biosciences, and SYSBIO Centre of Systems Biology, University Milano-Bicocca, Milan, Italy.
  • Janes MR; Kumquat Biosciences, Inc., San Diego, California.
  • Mikulski Z; La Jolla Institute for Allergy and Immunology, Division of Inflammation Biology, La Jolla, California.
  • Gualberto A; Kura Oncology, Inc., Cambridge, Massachusetts.
  • Molinolo AA; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Ferrara N; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California. sgutkind@ucsd.edu francis@kuraoncology.com.
  • Burrows F; Kura Oncology, Inc., San Diego, California. sgutkind@ucsd.edu francis@kuraoncology.com.
Mol Cancer Ther ; 19(9): 1784-1796, 2020 09.
Article em En | MEDLINE | ID: mdl-32727882
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Quinolonas / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Mutação / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Quinolonas / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Mutação / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2020 Tipo de documento: Article